Potential therapeutic effects of boswellic acids/Boswellia serrata extract in the prevention and therapy of type 2 diabetes and Alzheimer’s disease
- 20 September 2021
- journal article
- review article
- Published by Springer Science and Business Media LLC in Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie
- Vol. 394 (11), 2167-2185
- https://doi.org/10.1007/s00210-021-02154-7
Abstract
The link between diabetes and cognitive dysfunction has been reported in many recent articles. There is currently no disease-modifying treatment available for cognitive impairment. Boswellia serrata (B. serrata) is used traditionally to treat chronic inflammatory diseases such as type 2 diabetes (T2D), insulin resistance (IR), and Alzheimer’s disease (AD). This review aims to highlight current research on the potential use of boswellic acids (BAs)/B. serrata extract in T2D and AD. We reviewed the published information through June 2021. Studies have been collected through a search on online electronic databases (Academic libraries as PubMed, Scopus, Web of Science, and Egyptian Knowledge Bank). Accumulating evidence in preclinical and small human clinical studies has indicated that BAs/B. serrata extract has potential therapeutic effect in T2D and AD. According to most of the authors, the potential therapeutic effects of BAs/B. serrata extract in T2D and AD can be attributed to immunomodulatory, anti-inflammatory, antioxidant activity, and elimination of the senescent cells. BAs/B. serrata extract may act by inhibiting the IκB kinase/nuclear transcription factor-κB (IKK/NF-κB) signaling pathway and increasing the formation of selective anti-inflammatory LOX-isoform modulators. In conclusion, BAs/B. serrata extract may have positive therapeutic effects in prevention and therapy of T2D and AD. However, more randomized controlled trials with effective, large populations are needed to show a definitive conclusion about therapeutic efficacy of BAs/B. serrata extract in T2D and AD.Keywords
This publication has 148 references indexed in Scilit:
- Astrocyte Senescence as a Component of Alzheimer’s DiseasePLOS ONE, 2012
- A-90 day gavage safety assessment of Boswellia serrata in ratsToxicology International, 2012
- Clearance of p16Ink4a-positive senescent cells delays ageing-associated disordersNature, 2011
- Boswellia serrataClinical Pharmacokinetics, 2011
- Safety and toxicological evaluation of Aflapin®: A novel Boswellia-derived anti-inflammatory productToxicology Mechanisms and Methods, 2010
- Neural mechanisms of ageing and cognitive declineNature, 2010
- Topical Boswellic acids for treatment of photoaged skinDermatologic Therapy, 2010
- Effects of Topical Boswellic Acid on Photo and Age-Damaged Skin: Clinical, Biophysical, and Echographic Evaluations in a Double-Blind, Randomized, Split-Face StudyPlanta Medica, 2009
- Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetesNature Reviews Molecular Cell Biology, 2008
- Determination of Boswellic Acids in Brain and Plasma by High-Performance Liquid Chromatography/Tandem Mass SpectrometryAnalytical Chemistry, 2005